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Abstract: 
Aim: More than 50% of children report apian during venipuncture or intravenous cannulation 
and using local anaesthetics before needle procedures can lead to different success rates. This 
study examined how many needle procedures were successful at the first attempt when 
children received either a warm lidocaine and tetracaine patch or an eutectic mixture of 
lidocaine and prilocaine (EMLA) cream.  
Methods: We conducted this multicentre randomised controlled trial at three tertiary-level 
children’s hospitals in Italy in 2015. Children aged 3-10 years were enrolled in an emergency 
department, paediatric day hospital and paediatric ward and randomly allocated to receive a 
warm lidocaine and tetracaine patch or EMLA cream. The primary outcome was the success rate 
at the first attempt. 
Results: The analysis included 172 children who received  a warm lidocaine and tetracaine 
patch and 167 who received an EMLA cream. The needle procedure was successful at the first 
attempt in 158 children (92.4%) who received the warm patch and in 142 children (85.0%) 
who received the cream (p=0.03). The pain scores were similar in both groups. 
Conclusion: This study showed that the first-time needle procedure success was 7.4% higher in 
children receiving a warm lidocaine and tetracaine patch than EMLA cream.  
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Key notes:  
 
• Applying local anesthetics may influence success rates in children undergoing 
painful needle procedures.  
• We compared how many needles were inserted at the first attempt when children 
received a warm lidocaine and tetracaine patch or an eutectic mixture of lidocaine 
and prilocaine (EMLA) cream.  
• The three Italian hospitals who took part reported that the success rate was higher 
in children treated with the warm patch (92.4%) than the cream (85.0%). 
 
Abbreviations  
ARR, absolute risk reduction; CI, confidence intervals; EMLA, eutectic mixture of lidocaine 
and tetracaine; IQR, interquartile ranges; NNT, number need to treat; RR, relative risks  
 
INTRODUCTION 
Needle procedures are the most common painful and stressful interventions performed on 
children, with more than 50% reporting pain during venipunctures or intravenous cannulation 
(1). That is why pain management is recommended during these procedures (2). Topically 
applied local anaesthetics have been reported to be effective in reducing procedural pain and 
are widely used in these situations (3). Several formulations are available for this indication, 
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including tetracaine gel, 4% liposomal lidocaine cream, an eutectic mixture of lidocaine and 
prilocaine (EMLA) (4) and a warm lidocaine and tetracaine patch (5). 
While an EMLA cream is one of the most commonly used local anaesthetics, with substantial 
evidence of efficacy and safety in children (6), several studies have shown the effectiveness of a 
warm lidocaine and tetracaine patch in providing pain relief during vascular access, both in 
adults and children (7,8). However, to our knowledge, only two studies have compared the 
effectiveness of the pain relief provided by an EMLA cream and a warm lidocaine and tetracaine 
patch. These studies showed that the warm lidocaine and tetracaine patch had a more rapid 
analgesic effect than EMLA cream, acting in 30 minutes instead of 60 minutes. However, apart 
from the time it took for them to start providing pain relief, both formulations were equally 
effective (9,10).  
One relevant issue that needs to be addressed is the interference that these topical anaesthetics 
have with the actual needle procedures. Local anaesthetic formulations like EMLA cream 
containing prilocaine, , which is known to have a vasoconstrictor effect, resulting in epidermal 
blanching (11). However, after 60 minutes of application, EMLA cream does not cause a 
significant change in local skin blood flow (12) and it does not interfere with the success rate at 
the first attempt of venepuncture or intravenous cannulation (13). On the other hand, tetracaine 
is known to cause local vasodilatation, but the warm patch formulation, together with lidocaine, 
has a vasodilatatory effect that is less pronounced than other formulations that just contain 
tetracaine (14). To our knowledge, no study has compared the rates of needle procedure 
success at the first attempt using a warm lidocaine and tetracaine patch or EMLA cream in 
children as main outcome.  
The aim of this study was to investigate the first-time procedural success rates in children  who 
received a warm lidocaine and tetracaine patch or EMLA cream before undergoing 
venipuncture or intravenous cannulation.. 
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METHODS 
This study was a multicentre randomised controlled trial that involved three tertiary-level 
children’s hospitals in Italy: the Institute for Maternal and Child Health IRCCS Burlo Garofolo, 
Trieste, the Pausilipon Hospital, AORN Santobono Pausilipon, Naples and the Academic Hospital 
of Padua, Padua. The study was conducted between April and December 2015. Children were 
recruited in three different hospital settings: emergency departments, paediatric day hospitals 
and paediatric wards. We enrolled children from three to 10 years of age who needed 
venepuncture or intravenous cannulation. The exclusion criteria were: children who required 
emergency care, the use of topical, enteral or parenteral analgesics up to eight hours before the 
time of enrolment, a known allergy or hypersensibility to local anaesthetics, damaged, denuded 
or broken skin at the designated needle procedure site, the presence of a cognitive impairment 
or the inability to verbally report pain sensations. 
The eligible children were randomly allocated, to use Ralydan, a warm lidocaine and tetracaine 
patch (IBSA Farmaceutici srl, Lodi, Italy) or EMLA cream (AstraZeneca, Milano, Italy) on the site 
designated for the needle procedure.  
Ralydan is a drug delivery system that uses controlled heat to enhance the delivery to the skin 
of a 1:1 eutectic mixture of 70mg lidocaine base and 70mg tetracaine base. It consists of a 8.5cm 
x 6.0cm patch composed of a plastic tray, the drug formulation, an adhesive layer, a heating 
element and a release liner. The patch is activated when exposed to air, which triggers a 
chemical reaction and it warms the skin up to a maximum temperature of 40°C soon after it has 
been applied.   
The EMLA cream consists of an eutectic mixture of 25mg lidocaine and 25mg prilocaine and it is 
usually covered by a transparent occlusive dressing after it has been applied.  
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Operators who performed the procedure, examined the child’s skin, identified the most suitable 
sites for the needle procedure and then decided where to apply the local anaesthetic. In order to 
provide analgesia for at least for two possible attempts, two warm lidocaine and tetracaine 
patches, or a tube of EMLA cream divided into two applications, were applied on two different 
sites on each child. 
We know how long it would be before they took effect, so the warm lidocaine and tetracaine 
patches and the EMLA cream were applied at least 30 and 60 minutes, respectively, before the 
needle procedure (10). The topical analgesics were removed immediately before the needle 
procedure.  
A randomisation list, stratified by centre, with a fixed block size of 10, was generated using a 
computer-based method by an independent epidemiologist at the Clinical Epidemiology and 
Public Health Research Unit of the IRCCS Burlo Garofolo, Trieste, Italy. Allocation concealment 
was guaranteed by the use of sealed, opaque envelopes, consecutively numbered, each 
containing the allocation group. After obtaining informed consent, the healthcare staff 
performing the needle procedures opened the envelope marked with lowest number available 
and assigned the patient to the corresponding group. 
The primary outcome of this study was the success rate in performing venipuncture or 
intravenous cannulation at the first attempt. Secondary outcomes included: the procedural pain 
score, which was self-reported by children and recorded by the operator performing the 
procedure, whether operators thought that the local anaesthesia facilitated the procedure, 
whether the children would like the local anaesthesia to be used again before future needle 
procedures and the number and types of adverse events.  
Children from three to seven years of age reported their pain using the Wong-Baker scale (15) 
and children aged eight years or more, and the operators, reported pain with the Numerical 
Rating Scale (16). For the statistical analyses, scores from both scales were transformed into a 
numerical value from zero for no pain to 10 for maximum pain, in accordance with previous 
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studies, which demonstrated that scores reported using these two scales overlapped (15,17). A 
pain score from five to seven was considered to demonstrate moderate pain, while eight to 10 
was considered as severe pain. The procedural pain score was assessed immediately after the 
first needle procedure was attempted. Adverse events were recorded by the operator before the 
needle procedure - after they had removed the patch or cream - and 10 minutes after the 
procedure.  
Data were recorded using a standardised form, which was filled out by the operator who 
performed the procedure. The following variables were also collected for each procedure: the 
children’s age, sex and weight, the presence of fever or dehydration, the type, site and reason for 
the procedure, the job title and experience of the operator performing the procedure, the 
concomitant use of non-pharmacological distraction techniques and the hospital department 
where the procedure was performed. 
The study protocol had received approval from the Independent Bioethic Committee of the 
Institute for Maternal and Child Health IRCCS Burlo Garofolo and all the children’s parents 
provided written, informed consent for their participation.  The study was registered with 
ClinicalTrial.gov (NCT02519660) before the enrolment of the first participant. 
 
Statistical analyses 
This study was designed as a superiority trial. The data available in literature enabled us to 
estimate that the first-time success rate in children using the EMLA cream would be 85% 
(13,18). We hypothesized a success rate of 95% for the children using a warm lidocaine and 
tetracaine patch and by using the Fleiss method with continuity correction, we estimated that 
320 subjects -160 for each group – would be needed to carry out the study, with alfa = 0.05 and 
beta = 0.20. 
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Analyses were carried out according to the intention-to-treat principle. Continuous variables 
were reported as medians and interquartile ranges (IQR) and categorical data as numbers and 
percentages, relative risks (RR) and 95% confidence intervals (95% CI). For the primary 
outcome of the study the number needed to treat (NNT) was calculated as the inverse of the 
absolute risk reduction (1/ARR). Moreover, for categorical variables, the differences between 
the groups were evaluated with the chi-square test with the non-parametric Mann-Whitney U 
test, since a non-normal distribution of data was shown both visually and with the Kolmogorov-
Smirnov test. The data were analysed with SPSS software, version 21.0 (IBM Corp, Armonk, 
New York, USA). A double sided p value of <0.05 was considered statistically significant.   
 
RESULTS 
During the study period, we assessed 401 children for eligibility. Of these 13 declined to 
participate and 32 were excluded because they did not fulfil the study criteria, as 27 of them 
needed emergency care, three had used analgesic less than eight hours before enrolment and 
two had cognitive impairment. We enrolled 356 children: 178 were randomised to receive the  
warm lidocaine and tetracaine patch and 178 to receive the EMLA cream. After the application of the 
local anaesthetic, 17 children (4.8%) enrolled in the emergency department - six with a warm 
lidocaine and tetracaine patch and 11 with EMLA cream - did not undergo the procedure, because 
their clinical status was modified. Consequently, the analysis comprised 172 children treated with a 
warm lidocaine and tetracaine patch and 167 children treated with EMLA cream (Figure 1). In two 
children, one using a warm patch and one using the cream, the procedure was performed in a site not 
protected by the local anaesthetic. However, following the intention-to-treat principle, these subjects 
were included in their respective randomisation groups. No subject was lost during the follow up. 
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The baseline characteristics of the two groups were similar (Table 1). The mean age was six years old 
in both groups, ranging from 4.3-9.0 years in the warm patch group and from 4.0-8.0 years in the 
EMLA cream group (p=0.51). There was a slight prevalence of males in the EMLA group, but this 
was not statistically relevant (62.9% versus 52.9%, p=0.06). 
The success rate at the first attempt was higher in children using the warm lidocaine and tetracaine 
patch (n=158, 92.4%) than the EMLA cream (n=142,85.0%) (RR 1.09, 95% CI 1.01-1.17; p=0.03) 
(Table 2). The number need to treat (NNT), that is the number of children needed to be treated with a 
warm lidocaine and tetracaine patch in order to avoid one procedural failure, when compared to the 
EMLA cream, was 14 (1/0.074). With regards to the primary outcome of the study, we also performed 
a sensitivity analysis that considered all the randomised patients, including the subjects who had not 
received the needle procedure (17=4.8%) or had received it in a site not protected by local anaesthetic 
(2=0.5%). All these patients were classified as successful or all unsuccessful events. This sensitivity 
analysis showed no changes in the results of the study. The secondary outcomes results are reported in 
Table 2. The number of adverse events was higher in children using a warm lidocaine and tetracaine 
patch. However, adverse events in the two groups were not significantly different, as 11 children 
(6.4%) in the warm patch group versus five children (3.0%) in the EMLA cream group (p=0.14) 
experienced them. Only minor local adverse events were reported in both groups (Table 3).  
 
DISCUSSION 
This study was based on a large sample of children and showed that applying a warm lidocaine and 
tetracaine patch resulted in a higher first-time resulted in a higher first-time success rate, for 
venipuncture and intravenous cannulation in children, than following the application of EMLA cream.  
Venipuncture and intravenous cannulation are procedures that are frequently performed in children, 
and they are a well-known source of iatrogenic pain and distress. It has been proved that applying a 
local anaesthetic before a needle procedure decreases children’s pain and distress and increases the 
success rate of the procedure (13,18-20). Therefore, success at the first attempt is crucial in limiting 
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pain and distress in children and their parents and in sparing time and disposable materials. For these 
reasons, it is important to choose the formulation of local anaesthetic that results in the highest rate of 
success at the first attempt.  
When it came to the influence of different local anaesthetics on the needle procedure success rate, 
specific comparisons were only available for tetracaine gel and EMLA cream and these showed that 
tetracaine gel did not significantly increase the successful first-time cannulation rate compared to 
EMLA cream (21,22).  
Only two trials have previously compared a warm lidocaine and tetracaine patch and EMLA cream 
(9,10). The principal aim of both trials was to compare the analgesic effect of the two formulations 
and their effect on the procedural success rates were only reported as secondary outcomes. The trial 
performed on adult patients (10), did not show any difference between the two formulations on the 
procedural success rate and neither did the only existing paediatric trial (9). However, the paediatric 
study was flawed by the fact that the success rate was measured for both anaesthetics after 30 minutes 
of application, which is different from what is recommended in daily practice, as it is well known that 
the analgesic effect of the EMLA cream starts after 60 minutes of application (9). Moreover, it has 
been demonstrated that the EMLA cream may initially cause vasoconstriction, reducing the success 
rate of procedures performed within 60 minutes of it being applied (18,23). Our study was the first to 
investigate the effect of a warm lidocaine and tetracaine patch compared to EMLA cream on the 
success rate of needle procedures in children as the main outcome. We found a first-time success rate 
with a warm lidocaine and tetracaine patch of 92.4%, which was comparable to previous studies 
(8,10). On the other hand, the success rate of success for the EMLA cream was 85%, which was also 
comparable with previous paediatric studies, that ranged from 51% to 86% (13,21,24). 
Our results confirmed that a warm lidocaine and tetracaine patch and EMLA cream provided equally 
useful pain relief and that the number of children reporting significant procedural pain in this study 
was comparable to previous ones (8,25).  
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According to our data, the number needed to treat that would have beed necessary to avoid a 
venipuncture or cannulation failure was 14. Even though this was a high number, its impact should be 
considered in relation to the thousands of needle procedures performed daily using a local anaesthetic. 
This study did not include a cost-benefit analysis. However, we used a tube of EMLA cream (4.5 
Euros) or two warm lidocaine/tetracaine patches (6.6 Euros) for each child. As theEMLA cream was 
slightly cheaper, further studies on this topic are needed.  
This study had some limitations. First of all, it was not blinded, as blinding was not possible, given 
the different visible characteristics of the two drug formulations. Second, we did not include children 
younger than three years, but a warm lidocaine and tetracaine patch is not approved for this age 
group. Third, we did not use a vein visibility score (26) that would have allowed us to highlight the 
most complicated procedures. Further studies focused on children at high risk of needle procedure 
failure should be performed in the future, as they might show a more favourable NNT. Fourth, we did 
not collect the exact time of the analgesic application before procedures and how much time passed 
between the drug removal and the needle procedure execution. Thus, we cannot say how accurately 
the time protocol was respected in our study. Finally, data were analysed following the intention to 
treat principle and the children who underwent a needle procedure in a site not protected by local 
anaesthetic were not excluded from the analysis of our results. On the contrary, we excluded 17 
children randomised to the intervention groups from the analysis, as they had not been subjected to 
the procedure because of their clinical status was modified. However, these children on made up 4.8% 
randomised cohort and their inclusion in the analysis would not have changed the results. 
 
CONCLUSION 
This multicentre randomised clinical trial showed that a warm lidocaine and tetracaine patch led to a 
higher successful first-time venipuncture and intravenous cannulation rate in children when compared 
to EMLA cream. While this advantage may be of little statistical relevance in the general paediatric 
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population, it may be more relevant in children with difficult venous access. Further studies that focus 
on children at high risk of procedural failure are therefore needed.  
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Tables 
 
Table 1. Patients’ characteristics 
 
Patients’ characteristics Warm lidocaine and 
tetracaine patch group 
(n=172) 
EMLA group 
(n=167)  
p value 
Age in years, median (IQR) 6.0 (4.3-9.0) 6.0 (4.0-8.0) 0.51 
Male sex (%) 91 (52.9) 105 (62.9) 0.06 
Weight in kilograms, median (IQR) 24.0 (18.0-30.0) 23.0 (18.0-
30.0) 
0.66 
Presence of fever, number (%) 20 (11.6) 20 (12.0) 0.92 
Presence of dehydration, number (%) 5 (2.9) 10 (6.0) 0.17 
Aim of the procedure, number (%): 
- diagnosis 
- therapy 
 
 
143 (83.1) 
29 (16.9) 
 
 
134 (80.2) 
33 (19.8) 
 
 
0.49 
Type of the procedure, number (%): 
- venipuncture 
- intravenous cannulation 
 
87 (50.6) 
85 (49.4) 
 
 
83 (49.7) 
84 (50.3) 
 
0.87 
Site of the procedure, number (%):    
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- cubital fossa 
- hand 
- cubital fossa and hand 
118 (68.6) 
50 (29.1) 
4 (2.3) 
113 (67.7) 
50 (29.9) 
4 (2.4) 
0.98 
Distraction during the procedure, 
number (%) 
117 (68.0) 108 (64.7) 0.51 
Operator performing the procedure, 
number (%): 
- nurse 
- doctor 
 
 
 
165 (95.9) 
7 (4.1) 
 
 
 
158 (94.6) 
9 (5.4) 
 
 
 
0.57 
Procedures performed by the operator in 
the previous month, number (%): 
<5 
5-10 
>10 
 
 
10 (5.8) 
37 (21.6) 
124 (72.5) 
 
 
5 (3.0) 
32 (19.2) 
130 (77.8) 
 
 
0.35 
Department in which the procedure was 
performed, number (%): 
- emergency department 
- paediatric day hospital 
- paediatric ward 
 
 
59 (34.3) 
94 (54.7) 
19 (11.0) 
 
 
56 (33.5) 
83 (49.7) 
28 (16.8) 
 
 
0.30 
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Table 2. Main study outcomes 
 
Main study outcomes Warm lidocaine and 
tetracaine patch 
group (n=172) 
EMLA group 
(n=167) 
Risk 
ratio 
(95% 
CI) 
p value 
Procedural success at the first 
attempt, number (%)* 
158 (92.4) 142 (85.0) 1.09 
(1.01-
1.17) 
0.03 
Self-reported pain score, median 
(IQR) 
0.0 (0.0-2.0) 0.0 (0.0-2.0) - 0.07 
Self-reported pain score >4, 
number (%) 
18 (10.5) 15 (9.0) 1.17 
(0.61-
2.24) 
0.65 
Pain score reported by the 
operator, median (IQR) 
0.0 (0.0-0.0) 0.0 (0.0-0.0) - 0.80 
Children that would use the local 
anaesthetic again before future 
needle procedures, number (%)§  
155 (91.7) 154 (92.8) 0.99 
(0.93-
1.05) 
0.72 
Operators who thought that local 
anaesthesia facilitated the 
procedure, number (%) 
159 (92.4) 154 (92.2) 1.00 
(0.94-
1.07) 
0.94 
 
∗ Available for 171 subjects in the warm lidocaine and tetracaine patch group 
§ Available for 169 subjects in the warm lidocaine and tetracaine patch group and for 166 in 
EMLA group 
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Table 3. Adverse events, number and types 
 
Adverse events Warm 
lidocaine/tetracaine 
patch group (n=172) 
EMLA group 
(n=167) 
p value 
Number (%) 11 (6.4) 5 (3.0) 0.14 
Types: 
- local hyperaemia 
- local burning 
- local pain during the application or 
removing the anaesthetic 
- local blanching 
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Figure legend: 
Figure 1. Study algorithm (intention to treat analysis) 
 
 
 
